Evaluation of FlexSure™ HP
Helicobacter pylori has been the source of intensive research over the last twelve years since its discovery by Marshall and Warren. It is now accepted as the etiologic agent in chronic superficial gastritis, duodenal ulcers, and gastric ulcers. There has also been established a risk association between H. pylori infection and the development of gastric adenocarcinoma and lymphoma.5,7,13,14,19 The World Health Organization (WHO) in late 1994 classified H. pylori as a definite Category 1 carcinogen, bringing its significance to the point of a public health issue and suggesting the need for broad environmental controls. In February 1994, the National Institutes of Health, (NIH) convened a Consensus Panel which issued statements regarding H. pylori diagnosis and treatment.13 The consensus statement indicated that H. pylori infection should be diagnosed by any of the sensitive and specific methodologies available. In addition it stated that H. pylori infected ulcer patients should be treated with specific anti-microbial therapies to cure the infection.
KeywordsFormalin Urea Lymphoma Adenocarcinoma Bismuth
Unable to display preview. Download preview PDF.
- 2.Chong S. K. F., Lou Q. and Fitzgerald J. F. (1994) Amer J Gastroenterol, 89(8): poster 204.Google Scholar